Evidence-based medicine and myocardial protection--where is the evidence?

Z G Ferguson1, D E Yarborough1, B L Jarvis1

  • 1Medical University of South Carolina, Charleston, USA.

Perfusion
|October 10, 2014
PubMed

Insights

Current cardioplegic solutions lack robust human trials. More comparative research is needed to guide evidence-based selection beyond surgeon preference in cardiac surgery.

Area of Science:

  • Cardiovascular Surgery
  • Cardiothoracic Anesthesia
  • Cardiac Anesthesia

Background:

  • Cardioplegia is crucial for myocardial protection during cardiac surgery, limiting metabolic activity and enhancing ischemia tolerance.
  • Despite its long history, debate persists regarding the optimal cardioplegic solution for cardiac surgical procedures.
  • Current practices are influenced by surgeon preference due to a lack of definitive comparative research.

Purpose of the Study:

  • To review current cardioplegia practices in cardiac surgery.
  • To identify the paucity of high-quality human research supporting best practices in cardioplegia selection.
  • To highlight the need for evidence-based medicine in choosing cardioplegic agents.

Main Methods:

  • Systematic review of journal publications on commonly used cardioplegic solutions.
  • Assessment of microplegia, del Nido, Custodiol HTK, and 4:1 blood cardioplegia.
  • Evaluation of scientific validity, study design (retrospective vs. RCTs), and patient outcomes across different cardioplegia types.

Main Results:

  • Limited randomized clinical trials exist comparing cardioplegic solutions in human subjects.
  • Retrospective studies often report similar intraoperative and postoperative outcomes.
  • Specific solutions like del Nido cardioplegia lack substantial human trial data, hindering evidence-based application.

Conclusions:

  • Uniform study variables are needed for accurate systematic review and analysis of cardioplegia effectiveness.
  • Multicenter data collection and comparative effectiveness studies are recommended to guide cardioplegia selection.
  • Transitioning from surgeon preference to evidence-based medicine is essential for optimizing myocardial protection.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
341
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
514
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
387
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
887
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
767